αKlotho has been identified as a tumor suppressor and inhibits the insulin-like growth factor 1 (IGF1), FGF, and Wnt/β-catenin pathways; yet, the mode of action of αKlotho in cancer is a matter yet to be confirmed. The gene discussed is IGF1; the disease is neoplasm.